Oncology has been at the forefront of integrating pharmacogenomics into clinical practice, enabling more effective and personalized cancer treatments. This book examines the role of pharmacogenomics in the diagnosis, treatment, and management of various cancers, focusing on how genetic information can guide the selection of targeted therapies, immunotherapies, and chemotherapeutic agents. It covers the identification of genetic mutations and biomarkers that predict response to cancer drugs, the development of personalized treatment plans based on genomic profiles, and the management of resistance mechanisms through genetic insights. Designed for oncologists, pharmacogenomic researchers, and healthcare professionals, it provides comprehensive knowledge on leveraging genetic data to enhance cancer therapy precision and efficacy.
Amanda Roberts specializes in pharmacogenomics in oncology, focusing on how genetic factors influence the efficacy and safety of cancer treatments. Her work explores the role of genetic markers in predicting responses to chemotherapy, targeted therapies, and immunotherapy. Amanda advocates for personalized cancer treatments based on pharmacogenomic data to improve outcomes. She trains oncologists and pharmacologists to integrate genetic testing into cancer care for more effective and precise treatments.